{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:32:51Z","timestamp":1789151571778,"version":"build-2803163510"},"reference-count":36,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"The Sherman Foundation"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BR 6514\/1-1"],"award-info":[{"award-number":["BR 6514\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHW 914\/7-1"],"award-info":[{"award-number":["SCHW 914\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,16]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Context<\/jats:title><jats:p>Monocarboxylate transporter 8 (MCT8) deficiency is a rare genetic disease that leads to severe global developmental delay. MCT8 facilitates thyroid hormone (TH) transport across the cell membrane, and the serum TH profile is characterized by high T3 and low T4 levels. Recent studies have shown that the chemical chaperone sodium phenylbutyrate (NaPB) restored mutant MCT8 function and increased TH content in patient-derived induced pluripotent stem cells, making it a potential treatment for MCT8 deficiency.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>We aimed to assess the efficacy and safety of glycerol phenylbutyrate (GPB) in MCT8 deficiency.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We treated 2 monozygotic twins aged 14.5 years with MCT8 deficiency due to P321L mutation with escalating doses of GPB over 13 months. We recorded TH, vital signs, anthropometric measurements, and neurocognitive functions. Resting metabolic rate (RMR) was measured by indirect calorimetry. Serum metabolites of GPB were monitored as a safety measure. In vitro effects of NaPB were evaluated in MDCK1 cells stably expressing the MCT8P321L mutation. The effects of GPB were compared to the effects of DITPA and TRIAC, thyromimetic medications that the patients had received in the past.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>NaPB restored mutant MCT8 expression in MDCK1 cells and increased T3 transport into cells carrying the P321L mutation. GPB treatment reduced high T3 and increased low T4 levels. The patients showed a significant weight gain simultaneously with a reduction in RMR. Only minor neurocognitive improvement was observed, in hyperreflexia score and in cognitive functions. Serum metabolites did not exceed the toxic range, but elevated liver transaminases were observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In the first report of GPB treatment in MCT8 deficiency we found an improvement in TH profile and body mass index, with minor neurodevelopmental changes.<\/jats:p><\/jats:sec>","DOI":"10.1210\/clinem\/dgae146","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T08:13:58Z","timestamp":1710231238000},"page":"2589-2601","source":"Crossref","is-referenced-by-count":4,"title":["Glycerol Phenylbutyrate Treatment of 2 Patients With Monocarboxylate Transporter 8 Deficiency"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4745-4232","authenticated-orcid":false,"given":"Amnon","family":"Zung","sequence":"first","affiliation":[{"name":"Pediatric Endocrinology Unit, Kaplan Medical Center , Rehovot 76100 , Israel"},{"name":"Faculty of Medicine, Hebrew University of Jerusalem , Jerusalem 12000 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Sonntag","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Biochemie und Molekularbiologie, Medizinische Fakult\u00e4t, Rheinische Friedrich-Wilhelms-Universit\u00e4t Bonn , Bonn 53115 , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Schweizer","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Biochemie und Molekularbiologie, Medizinische Fakult\u00e4t, Rheinische Friedrich-Wilhelms-Universit\u00e4t Bonn , Bonn 53115 , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Banne","sequence":"additional","affiliation":[{"name":"The Genetic Institute, Edith Wolfson Medical Center , Holon 5822012 , Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"Braun","sequence":"additional","affiliation":[{"name":"Institut f\u00fcr Biochemie und Molekularbiologie, Medizinische Fakult\u00e4t, Rheinische Friedrich-Wilhelms-Universit\u00e4t Bonn , Bonn 53115 , Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,3,12]]},"reference":[{"issue":"2","key":"2024091609262551500_dgae146-B1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1210\/endrev\/bnz008","article-title":"Thyroid hormone transporters","volume":"41","author":"Groeneweg","year":"2020","journal-title":"Endocrine Rev"},{"issue":"7","key":"2024091609262551500_dgae146-B2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-8587(20)30153-4","article-title":"Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study","volume":"8","author":"Groeneweg","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"41","key":"2024091609262551500_dgae146-B3","doi-asserted-by":"crossref","first-page":"40128","DOI":"10.1074\/jbc.M300909200","article-title":"Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter","volume":"278","author":"Friesema","year":"2003","journal-title":"J Bio Chem"},{"issue":"6","key":"2024091609262551500_dgae146-B4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1677\/JME-09-0043","article-title":"Surface translocation and tri-iodothyronine uptake of mutant MCT8 proteins are cell type-dependent","volume":"43","author":"Kinne","year":"2009","journal-title":"J Mol Endocrinol"},{"issue":"12","key":"2024091609262551500_dgae146-B5","doi-asserted-by":"crossref","first-page":"E2799","DOI":"10.1210\/jc.2014-2162","article-title":"Mutations of the thyroid hormone transporter MCT8 cause prenatal brain damage and persistent hypomyelination","volume":"99","author":"L\u00f3pez-Esp\u00edndola","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2024091609262551500_dgae146-B6","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00429-019-01896-8","article-title":"Thyroid hormone availability in the human fetal brain: novel entry pathways and role of radial glia","volume":"224","author":"L\u00f3pez-Esp\u00edndola","year":"2019","journal-title":"Brain Struct Funct"},{"issue":"6","key":"2024091609262551500_dgae146-B7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.stem.2017.04.002","article-title":"Modeling psychomotor retardation using iPSCs from MCT8-deficient patients indicates a prominent role for the blood-brain barrier","volume":"20","author":"Vatine","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"12","key":"2024091609262551500_dgae146-B8","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1210\/jc.2012-2556","article-title":"Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency","volume":"97","author":"Verge","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2024091609262551500_dgae146-B9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S2213-8587(19)30155-X","article-title":"Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single group, open-label, phase 2 trial","volume":"7","author":"Groeneweg","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"2024091609262551500_dgae146-B10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1086\/431313","article-title":"Allan-Herndon-Dudley syndrome and the monocarboxylate transporter 8 (MCT8) gene","volume":"77","author":"Schwartz","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"3","key":"2024091609262551500_dgae146-B11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/humu.23140","article-title":"Clinical and molecular characteristics of SLC16A2 (MCT8) mutations in three families with the Allan-Herndon-Dudley syndrome","volume":"38","author":"Novara","year":"2017","journal-title":"Hum Mutat"},{"issue":"1","key":"2024091609262551500_dgae146-B12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/humu.20808","article-title":"Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutations","volume":"30","author":"Visser","year":"2009","journal-title":"Hum Mutat"},{"issue":"6","key":"2024091609262551500_dgae146-B13","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s11011-019-00464-7","article-title":"Novel mutations in SLC16A2 associated with a less severe phenotype of MCT8 deficiency","volume":"34","author":"Masnada","year":"2019","journal-title":"Metab Brain Dis"},{"issue":"12","key":"2024091609262551500_dgae146-B14","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1210\/en.2015-1393","article-title":"Efficient activation of pathogenic Phe501 mutation in monocarboxylate transporter 8 by chemical and pharmacological chaperones","volume":"156","author":"Braun","year":"2015","journal-title":"Endocrinology"},{"issue":"3","key":"2024091609262551500_dgae146-B15","first-page":"678","article-title":"The chemical chaperone phenylbutyrate rescues MCT8 mutations associated with milder phenotypes in patients with Allan-Herndon-Dudley syndrome","volume":"158","author":"Braun","year":"2017","journal-title":"Endocrinology"},{"issue":"5","key":"2024091609262551500_dgae146-B16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000507439","article-title":"The protein translocation defect MCT8L291R is rescued by sodium phenylbutyrate","volume":"9","author":"Braun","year":"2020","journal-title":"Eur Thyroid J"},{"issue":"7","key":"2024091609262551500_dgae146-B17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1089\/thy.2021.0643","article-title":"Sodium phenylbutyrate rescues thyroid hormone transport in brain endothelial-like cells","volume":"32","author":"Braun","year":"2022","journal-title":"Thyroid"},{"issue":"3","key":"2024091609262551500_dgae146-B18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1469-8749.1989.tb04003.x","article-title":"The gross motor function measure: a means to evaluate the effects of physical therapy","volume":"31","author":"Russell","year":"1989","journal-title":"Dev Med Child Neurol"},{"key":"2024091609262551500_dgae146-B19","volume-title":"Bayley Scales of Infant and Toddler Development, 3rd ed","author":"Bayley","year":"2006"},{"key":"2024091609262551500_dgae146-B20"},{"issue":"4","key":"2024091609262551500_dgae146-B21","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymgme.2013.09.017","article-title":"Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratio","volume":"110","author":"Mokhtarani","year":"2013","journal-title":"Mol Genet Metab"},{"key":"2024091609262551500_dgae146-B22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ymgmr.2016.07.003","article-title":"Barriers to drug adherence in the treatment of urea cycle disorders: assessment of patients, caregiver and provider perspectives","volume":"8","author":"Shchelochkov","year":"2016","journal-title":"Mol Genet Metab Rep"},{"key":"2024091609262551500_dgae146-B23","first-page":"2346","volume-title":"Nelson Textbook of Pediatrics","author":"Bernstein","year":"2022"},{"key":"2024091609262551500_dgae146-B24","first-page":"1","article-title":"CDC growth charts United States","volume":"314","author":"Kuczmarski","year":"2000","journal-title":"Adv Data"},{"issue":"7","key":"2024091609262551500_dgae146-B25","doi-asserted-by":"crossref","first-page":"e15658","DOI":"10.14814\/phy2.15658","article-title":"Validity and reproducibility of a whole-room indirect calorimeter for the estimation of VO2, VCO2, and resting metabolic rate","volume":"11","author":"Henriksen","year":"2023","journal-title":"Physiol Rep"},{"issue":"9","key":"2024091609262551500_dgae146-B26","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/oby.23476","article-title":"Energy expenditure measurements are reproducible in different whole-room indirect calorimeters in human","volume":"30","author":"Stinson","year":"2022","journal-title":"Obesity (Silver Spring)"},{"issue":"1","key":"2024091609262551500_dgae146-B27","doi-asserted-by":"crossref","first-page":"14343","DOI":"10.1038\/s41598-020-71001-1","article-title":"An appraisal of whole-room indirect calorimeters and a metabolic cart for measuring resting and active metabolic rates","volume":"10","author":"Chen","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"2024091609262551500_dgae146-B28","doi-asserted-by":"crossref","first-page":"576","DOI":"10.23736\/S1973-9087.17.04796-7","article-title":"Inter- and intra-rater reliability of the modified ashworth scale: a systematic review and meta-analysis","volume":"54","author":"Meseguer-Henarejos","year":"2018","journal-title":"Eur J Phys Rehabil Med"},{"issue":"1-2","key":"2024091609262551500_dgae146-B29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ymgme.2014.06.005","article-title":"Sodium phenylbutyrate decreases plasma branched-chain amino acids in patients with urea cycle disorders","volume":"113","author":"Burrage","year":"2014","journal-title":"Mol Genet Metab"},{"key":"2024091609262551500_dgae146-B30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.mce.2016.05.017","article-title":"The long N-terminus of the human monocarboxylate transporter 8 is a target of ubiquitin-dependent proteasomal degradation which regulates protein expression and oligomerization capacity","volume":"434","author":"Zwanziger","year":"2016","journal-title":"Mol Cell Endocrinol"},{"issue":"7a","key":"2024091609262551500_dgae146-B31","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1079\/PHN2005800","article-title":"Measurement of energy expenditure","volume":"8","author":"Levine","year":"2005","journal-title":"Public Health Nut"},{"issue":"2","key":"2024091609262551500_dgae146-B32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1203\/00006450-199002000-00022","article-title":"Energy expenditure in obese and nonobese adolescents","volume":"27","author":"Bandini","year":"1990","journal-title":"Pediatr Res"},{"issue":"12","key":"2024091609262551500_dgae146-B33","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1210\/en.2013-1150","article-title":"Mct8-deficient mice have increased energy expenditure and reduced fat mass that is abrogated by normalization of serum T3 levels","volume":"154","author":"Di Cosmo","year":"2013","journal-title":"Endocrinology"},{"issue":"5","key":"2024091609262551500_dgae146-B34","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1089\/thy.2020.0306","article-title":"Prenatal treatment of thyroid hormone cell membrane transport defect caused by MCT8 gene mutation","volume":"31","author":"Refetoff","year":"2021","journal-title":"Thyroid"},{"issue":"12","key":"2024091609262551500_dgae146-B35","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/me.2014-1135","article-title":"In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency","volume":"28","author":"Kersseboom","year":"2014","journal-title":"Mol Endocrinol"},{"issue":"11","key":"2024091609262551500_dgae146-B36","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1242\/dmm.027227","article-title":"Pharmacological treatment and BBB-targeted genetic therapy for MCT8-dependent hypomyelination in zebrafish","volume":"9","author":"Zada","year":"2016","journal-title":"Dis Model Mech"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae146\/57050398\/dgae146.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/10\/2589\/59135667\/dgae146.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/10\/2589\/59135667\/dgae146.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T01:27:19Z","timestamp":1731547639000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/10\/2589\/7625621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,12]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,3,12]]},"published-print":{"date-parts":[[2024,9,16]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae146","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,3,12]]}}}